Distinguishing benign from malignant bowel obstruction in patients with malignancy: findings at MR imaging.

PURPOSE

To retrospectively evaluate the features of benign versus malignant bowel obstruction on unenhanced and gadolinium-enhanced spoiled gradient-echo magnetic resonance (MR) images in patients with malignancy.

MATERIALS AND METHODS

Forty-eight patients with malignancy and bowel obstruction underwent abdominal and pelvic MR imaging. Two blinded radiologists independently evaluated each study for dilated bowel, transition point, level of obstruction, obstructing mass, mural thickening and enhancement, and peritoneal disease. Benign obstruction was recorded if no mass was present and if mural thickening (when present) was segmental or diffuse. Malignant bowel obstruction was recorded if there was a mass, a disseminated abdominal tumor, or focal mural thickening. MR images were compared with surgical findings, follow-up imaging studies, and clinical outcome. chi2 test and Fisher exact test were used to assess the relationship between the MR features and benign versus malignant obstruction.

RESULTS

Bowel obstruction had a benign cause in 19 patients and a malignant cause in 29 patients. Observer 1 correctly characterized benign bowel obstruction in 17 of 19 patients and malignant bowel obstruction in 27 of 29 patients. The sensitivity of observer 1 for characterizing malignant obstruction was 93%, specificity was 89%, and accuracy was 92%. Observer 2 correctly characterized benign bowel obstruction in 18 of 19 patients and malignant bowel obstruction in 26 of 29 patients. The sensitivity of observer 2 for characterizing malignant obstruction was 90%, specificity was 95%, and accuracy was 92%. Malignant bowel obstruction was present in 24 of 25 patients with an obstructing mass (P <.001). All 16 patients with focal mural thickening had malignant obstruction. Benign obstruction was present in four of five patients with diffuse mural thickening. Segmental mural thickening occurred in four patients with serosal metastases and in 11 patients with benign bowel obstruction. More extensive peritoneal thickening and enhancement correlated with malignant obstruction.

CONCLUSION

In patients with malignancy who have symptoms indicative of bowel obstruction, gadolinium-enhanced MR imaging can help distinguish benign from malignant causes of bowel obstruction.